Synthetic consortia of nanobody-coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis-associated diseases and co-morbidities
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetic consortia of nanobody-coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis-associated diseases and co-morbidities
Authors
Keywords
-
Journal
Microbial Biotechnology
Volume 12, Issue 1, Pages 58-65
Publisher
Wiley
Online
2018-12-22
DOI
10.1111/1751-7915.13355
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Synthetic Bacterial Cell-Cell Adhesion Toolbox for Programming Multicellular Morphologies and Patterns
- (2018) David S. Glass et al. CELL
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibacterial Weapons: Targeted Destruction in the Microbiota
- (2018) Benoit Chassaing et al. TRENDS IN MICROBIOLOGY
- Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: A population-based cohort study
- (2018) Jenny Tran et al. PLOS MEDICINE
- What are the economic barriers of antibiotic R&D and how can we overcome them?
- (2018) Mathew Renwick et al. Expert Opinion on Drug Discovery
- Live bacterial biotherapeutics in the clinic
- (2018) Luis G Bermúdez-Humarán et al. NATURE BIOTECHNOLOGY
- Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria
- (2018) Vincent M Isabella et al. NATURE BIOTECHNOLOGY
- Multimorbiditätsmanagement im Alltagsdilemma
- (2017) E. Battegay et al. INTERNIST
- The P4 Health Spectrum – A Predictive, Preventive, Personalized and Participatory Continuum for Promoting Healthspan
- (2017) Michael Sagner et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models
- (2017) In Young Hwang et al. Nature Communications
- Tumour-targeting bacteria-based cancer therapies for increased specificity and improved outcome
- (2017) Sebastian Felgner et al. Microbial Biotechnology
- Sustainable therapies by engineered bacteria
- (2017) Beatriz Álvarez et al. Microbial Biotechnology
- Escherichia coli surface display for the selection of nanobodies
- (2017) Valencio Salema et al. Microbial Biotechnology
- The DIY Digital Medical Centre
- (2017) James Kenneth Timmis et al. Microbial Biotechnology
- Nanobodies as therapeutics: big opportunities for small antibodies
- (2016) Sophie Steeland et al. DRUG DISCOVERY TODAY
- Precision medicine in cardiology
- (2016) Elliott M. Antman et al. Nature Reviews Cardiology
- Personalized Cardiovascular Disease Prediction and Treatment—A Review of Existing Strategies and Novel Systems Medicine Tools
- (2016) Elias Björnson et al. Frontiers in Physiology
- Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer
- (2016) Isabel Van Audenhove et al. EBioMedicine
- Biome engineering-2020
- (2016) Harald Brüssow Microbial Biotechnology
- Molecular weaponry: diverse effectors delivered by the Type VI secretion system
- (2015) Juliana Alcoforado Diniz et al. CELLULAR MICROBIOLOGY
- Engineered bacteria as therapeutic agents
- (2015) Carlos Piñero-Lambea et al. CURRENT OPINION IN BIOTECHNOLOGY
- Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies
- (2015) Jacoline C. Bouvy et al. DRUG SAFETY
- Precision Medicine — Personalized, Problematic, and Promising
- (2015) J. Larry Jameson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review
- (2015) Noortje G Rossen WORLD JOURNAL OF GASTROENTEROLOGY
- Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity
- (2014) Zhongyi Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Nanobody: The “Magic Bullet” for Molecular Imaging?
- (2014) Rubel Chakravarty et al. Theranostics
- Programming Controlled Adhesion of E. coli to Target Surfaces, Cells, and Tumors with Synthetic Adhesins
- (2014) Carlos Piñero-Lambea et al. ACS Synthetic Biology
- Nanobodies: Natural Single-Domain Antibodies
- (2013) Serge Muyldermans Annual Review of Biochemistry
- Targeting tumors with nanobodies for cancer imaging and therapy
- (2013) Sabrina Oliveira et al. JOURNAL OF CONTROLLED RELEASE
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- The road from systems biology to systems medicine
- (2013) Olaf Wolkenhauer et al. PEDIATRIC RESEARCH
- Selection of Single Domain Antibodies from Immune Libraries Displayed on the Surface of E. coli Cells with Two β-Domains of Opposite Topologies
- (2013) Valencio Salema et al. PLoS One
- Concepts of comorbidities, multiple morbidities, complications, and their clinical epidemiologic analogs
- (2013) Anne Ording et al. Clinical Epidemiology
- Revolutionizing medicine in the 21st century through systems approaches
- (2012) Leroy Hood et al. Biotechnology Journal
- Long-term monitoring of the human intestinal microbiota composition
- (2012) Mirjana Rajilić-Stojanović et al. ENVIRONMENTAL MICROBIOLOGY
- Role of Periplasmic Chaperones and BamA (YaeT/Omp85) in Folding and Secretion of Intimin from Enteropathogenic Escherichia coli Strains
- (2009) G. Bodelon et al. JOURNAL OF BACTERIOLOGY
- Bacterial Community Variation in Human Body Habitats Across Space and Time
- (2009) E. K. Costello et al. SCIENCE
- Systems biology approaches to bioremediation
- (2008) Víctor de Lorenzo CURRENT OPINION IN BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now